Oxford Biomedica Share News (OXB)
OXB Share
OXB Share
OXB Share
OXB Share
OXB
OXB Share
OXB Level 2
OXB Live
OXB Broker
OXB Directors
OXB Financial
OXB
OXB Short
OXB
Last checked at -
Tue, 06th Jul 2021 15:52
Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Chief Business Officer Jason Slingsby exercises nil-cost options for 1,584 shares and sells all of them for 1,298.5 pence each, worth GBP20,569, on Friday last week.
Current stock price: 1,326.52p
Year-to-date change: up 29%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Covid-19 vaccine producer Oxford Biomedica swung to a profit in the half year on the back of a surge in revenues through its partnership deal with AstraZeneca and announced that Serum Institute of India has agreed to invest £50m in the group in return for a 3.9% stake in the company.
Read more
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Kingfisher top FTSE 100 loser despite positive results* Royal Dutch Shell sells U.S. oilfield assets* Stagecoast surges on merger talks wit...
Read moreUK earnings, trading statements calendar - next 7 days
Read moreReNeuron taps Oxford Biomedica executive Catherine Isted as CFO
Read moreOXFORD, England, July 28 (Reuters) - British Foreign Secretary Dominic Raab warned that the world would not be vaccinated until 2024 under current rates and urged other countries to join Britain in donating shots to poorer nations to bring that d...
Read moreEXECUTIVE CHANGES: Oxford BioMedica adds former Teva exec to board
Read moreBROKER RATINGS: Citigroup prefers Beazley over Hiscox and Lancashire
Read moreBROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold
Read moreBROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado
Read moreJune 18 (Reuters) - AstraZeneca must deliver COVID-19 vaccines to the European Union also from a factory in Britain if it is needed to meet its commitments with the EU, a judge ruled on Friday, according to a lawyer representing the EU.The company...
Read more* Judge orders AstraZeneca to deliver doses by strict deadlines* EU had asked for more doses to be shipped earlier* AstraZeneca may have breached contract in reserving doses for UK* Second legal case will establish whether contract was breached (...
Read moreTRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend
Read moreEXECUTIVE CHANGES: Vectura senior director departs amid takeover offer
Read moreDIRECTOR DEALINGS: Renalytix AI CEO sells USD2 million in shares
Read more
Last checked at